President Trump authorized the use of controversial COVID-19 treatment, experts baffled
Home » More News » President Trump authorized the use of controversial COVID-19 treatment, experts baffled
29 August, 2020
On August 23, US President Donald Trump announced that his administration has granted an emergency authorization of convalescent plasma to treat hospitalized Covid-19 patients.
However, some of the nation’s top health officials say that data from clinical trials is too weak to support widespread application of the treatment, reports CNBC.
“Today’s action will dramatically expand access to this treatment. We’re removing unnecessary barriers and delays,” Trump said at a White House press conference about the authorisation.
He also claimed that blood plasma treatment has cut Covid-19 mortality by 35 percent.
The said method uses blood from Covid-19 patients who have recovered and built antibodies against the virus and infuses it into people with the disease to prevent severe cases, according to the Mayo Clinic, which is conducting studies on the treatment.
The FDA said the authorisation was granted because ‘it is reasonable to believe that convalescent plasma may be effective in treating Covid-19 patients’.
White House coronavirus advisor Dr Anthony Fauci and National Institutes of Health Director Dr Francis Collins alongside other experts noted that the data was too weak which should have barred the FDA from granting emergency use for the blood treatment.
On last week’s Democratic National Convention, a speech delivered by Democrat Representative in New York Alexandria Ocasio-Cortez was misquoted by NBC News on Twitter. A rightfully outraged Cortez responded immediately.Read More...
In a shocking turn of event, the US Department of Justice (DOJ) accused Yale University, perhaps the epitome of American Education, of illegal discrimination against Asian American and White applicants in violation of federal civil rights law Thursday following an investigation. Read More...